Sunday, November 19, 2023 7:06:32 PM
The current share price has fully priced in a dilutive raise and slow revenue growth next year IMO (e.g. Total Daxi annual sales growth of less than 100% from 2023 to 2024). Revance is trading like a commodity NT that will never get to much more than 10% US market share in Aesthetics and will be forced to compete on price to achieve that share.
A binary outcome is thus pending in the not too distant future.
A $12M to $15M Daxi sales shortfall the last 2 quarters (by my estimates) has decimated $2.5B in market cap: that is a $170M hit to market cap for every $1M in revenue miss. The converse may also hold true in the event that Daxi sales materially beat and accelerate going forward.
The January 9th, 2023 pre release: https://d18rn0p25nwr6d.cloudfront.net/CIK-0001479290/8429c6d6-858e-445e-a255-ccdb265540f8.pdf
Revance Provides an Update on DAXXIFY® Commercial Launch and
Preliminary Fourth Quarter and Full Year 2022 Financial Results
• DAXXIFY® PrevU program off to strong start with ~400 select practice partners and thousands of patients treated, generating positive
feedback and strong, early uptake
• Preliminary unaudited Q4 DAXXIFY® revenue from PrevU of between $10.5 million and $11.5 million
• Preliminary unaudited Q4 RHA® Collection revenue of between $34.0 million and $35.0 million, a YoY increase of approximately 45%
With regard to the above preannounce, the street clearly didn't expect PrevU sales to come in at $11M from such a small number of accounts and the stock rose to close at $30.41 on Monday after having closed at $19.71 on Friday (up 54% in a day) It gapped up $3 on the opening trade and then jumped up $8 soon after leaving no time to buy anywhere near where it closed the prior trading day. In this case a $5M Daxi revenue beat led to a $900M gain in market cap in a single day: coincidentally: also a 180:1 ratio of market cap gain to Daxi revenue upside.
I expect algorithmic trading will continue to dominate and drive large volatility in share price for the foreseeable future based on Daxi revenue beats/fails.
Let's assume 150 sales reps bring on 800 to 1000 new accounts in Q4 due to the big Daxi price drop: 40 vials/account at $310/vial = $10 to 12M of additional quarterly revenue that is stacking on reorders from the existing 2500 accounts. They stated on their last CC that the average reordering account last quarter ordered 43% more vials than their previous order so if reordering accounts generate $20 to $28M of sales and new accounts add $10 to 12M we can see Q4 Daxi sales coming in around $35M plus/minus (60% Q/Q growth). Add another solid RHA quarter with growth above Q3 at $36M and we get to revenue in the low $70Ms. Current mean analyst estimate is $67M (range of $63M to $77M).
a 180 to 1 leverage ratio on Market cap gain to quarterly Daxi sales beat must be piquing the interest of some hedge fund managers as well as pushing some shorts to cover soon. We could sure use some help from the wallstreet bets reddit crowd right about now. 😀
Recent RVNC News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:32:37 AM
- Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm • PR Newswire (US) • 09/27/2024 01:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:15:36 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/16/2024 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:06:45 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 09/05/2024 09:27:28 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 09/05/2024 08:45:25 PM
- Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 08/13/2024 01:29:06 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/12/2024 09:18:26 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Revance Therapeutics, Inc. • PR Newswire (US) • 08/12/2024 07:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 01:20:58 PM
- Crown Laboratories and Revance Announce Entry Into Merger Agreement • PR Newswire (US) • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 01:00:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:34:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:07:57 PM
- Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 08/08/2024 08:05:00 PM
- Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • Business Wire • 08/01/2024 08:05:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM